4
Changes in Ownership
Harmony Biosciences Holdings, Inc. Filed Acc 0001104659-22-042846
Chief Commercial Officer sold 14,471 shares at an average $49.63 ($718,170)
- Chief Commercial Officer acquired 14,471 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Dierks Jeffrey · Chief Commercial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-04-01 | Exercise or conversion : show line 1 in the form | +14,471 | $24.00 | $347,304 | 14,471 | D |
| 2022-04-01 | Sale : show line 2 in the form | −6,765 | $49.36 | $333,893 | 7,706 | D |
| 2022-04-01 | Sale : show line 3 in the form | −7,706 | $49.87 | $384,277 | 0 | D |
| Open-market sales · 14,471 sh · avg $49.63 · $718,170 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-04-01 | Exercise or conversion : show line 4 in the form Stock Option | −14,471 | 116,085 | D |
Loading xslF345X03/tm2211710-1_4seq1.xml…